TD Asset Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-43,657
| Closed | -$436K | – | 1525 |
|
|
2021
Q4 | $436K | Hold |
43,657
| – | – | ﹤0.01% | 1399 |
|
|
2021
Q3 | $435K | Hold |
43,657
| – | – | ﹤0.01% | 1412 |
|
|
2021
Q2 | $435K | Hold |
43,657
| – | – | ﹤0.01% | 1407 |
|
|
2021
Q1 | $440K | Hold |
43,657
| – | – | ﹤0.01% | 1418 |
|
|
2020
Q4 | $459K | Buy |
+43,657
| New | +$459K | ﹤0.01% | 1345 |
|